Manfro, Pedro H. http://orcid.org/0000-0003-0950-6844
Pereira, Rivka B. http://orcid.org/0000-0002-0472-9398
Rosa, Martha
Cogo-Moreira, Hugo http://orcid.org/0000-0001-9411-9237
Fisher, Helen L. http://orcid.org/0000-0003-4174-2126
Kohrt, Brandon A. http://orcid.org/0000-0002-3829-4820
Mondelli, Valeria http://orcid.org/0000-0001-8690-6839
Kieling, Christian http://orcid.org/0000-0001-7691-4149
Funding for this research was provided by:
MQ: Transforming Mental Health (MQBF/1 IDEA)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Economic and Social Research Council (ES/S012567/1)
UK Medical Research Council (MC_PC_MR/R019460/1)
Article History
Received: 13 April 2021
Accepted: 23 September 2021
First Online: 2 December 2021
Declarations
:
: Dr. Valeria Mondelli has received research funding from Johnson & Johnson, a pharmaceutical company interested in the development of anti-inflammatory strategies for depression, but the research described in this paper is unrelated to this funding. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The study was approved by the Brazilian National Ethics Committee (CAAE 50473015.9.0000.5327).
: Participants and/or primary caregivers provided written dissent terms if they refused to participate.
: Not applicable.